ALB and breast cancer: Whereas present data suggest a decreased FARI, i.e., decreased fibrinogen and elevated albumin, to be associated with impaired survival, previous studies of ovarian, cervical, and breast cancer report either an elevated FARI or a decreased albumin-to-fibrinogen ratio, i.e., elevated fibrinogen and decreased albumin, to be associated with impaired survival.